Cognitive impairment pain can be eased with Matrifen®

Matrifen® from Nycomed relieves the pain of cognitive impairment and has fewer adverse effects than other similar products.

Cognitive impairment comes with severe pain. These can now be relieved with the Matrifen® fentanyl pain patch.

>> More information on cognitive impairment and Matrifen®

Matrifen® is beneficial for patients with respiratory depression, hypoventilation, cognitive impairment, peripheral diabetic neuropathy, osteoarthritis, rheumatoid arthritis and cancer pain and is approximately 50 to 100 times as potent as morphine.

It has fewer adverse effects compared to morphine tablets and other oral formulations of opiod analgesics and is approximately 50 to 100 times as potent as morphine.

About Nycomed
Nycomed is a pharmaceutical company dedicated to meeting needs in Europe. The company provides hospital products throughout the region and general practitioner and pharmacy medicines in selected markets.

New products are sourced through licensing agreements with research companies. Here Nycomed provides late-stage clinical development, registration and marketing. Nycomed employs about 3,500 people throughout Europe and Russia-CIS.

Efficient fentanyl drug utilization | Silicone adhesion layer | Steady-state concentration of fentanyl